Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors

Environmental Health Perspectives

Volumn 109, Issue 8, 2001, Pages 757-764

  Van Loveren, Henk ^a   Van Amsterdam, Jan G C ^a   Vandebriel, Rob J ^a   Kimman, Tjeerd G ^a   Rümke, Hans C ^a   Steerenberg, Peter S ^a   Vos, Jeff G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Age; Antibody responses; Epidemiology; Genetic factors; Immunotoxicity; Nutritional factors; Stress; Vaccination

Indexed keywords

CYCLOSPORIN A; DIBENZOFURAN; DIOXIN; DIPHTHERIA TETANUS VACCINE; HEPATITIS B VACCINE; INACTIVATED VIRUS VACCINE; MONOCLONAL ANTIBODY; ORAL POLIOMYELITIS VACCINE; ORGANOCHLORINE DERIVATIVE; POLIOMYELITIS VACCINE; POLYCHLORINATED BIPHENYL; T LYMPHOCYTE ANTIGEN; TETANUS TOXOID; VACCINE;

AGE; AGED; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CHILD; CIGARETTE SMOKING; CONTROLLED STUDY; DIET; DRUG RESPONSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; GENDER; GRAFT REJECTION; HEREDITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL PARAMETERS; INFECTION; MEDICAL LITERATURE; MENTAL STRESS; NONHUMAN; NUTRITION; PATHOGENICITY; POPULATION; PRIORITY JOURNAL; PROTECTION; RECIPIENT; REVIEW; SENSITIZATION; T LYMPHOCYTE; TITRIMETRY; VACCINATION;

EID: 0034807821     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.01109757     Document Type: Review

References (118)

1. Principles and Methods for Assessing Direct Immunotoxicity Associated with Exposure to Chemicals
2. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests
3. Risk assessment in immunotoxicology. II. Relationship between immune and host resistance tests
4. Toxicological consequences of Arachlor 1254 ingestion by female rhesus (Macaca mulatta) monkeys. Prebreeding phase: Clinical and analytical laboratory findings
5. The immunologic evaluation of the Yucheng children
6. Report of the Bilthoven Symposium: Advancement of epidemiological studies in assessing the human health effects of immunotoxic agents in the environment and the workplace
7. Infection and cyclosporin
8. Cytoreductive drugs
9. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children
10. Human anti-mouse antibody suppression with cyclosporin A
11. Immunity to diphtheria, pertussis tetanus and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy
12. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation
13. Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation
14. Routine immunizations in adult renal transplant recipients
15. Impaired cellular immune response in harbour seals (Phoca vitulina) fed environmentally contaminated herring
16. Evaluation of the humoral immune response of children with low level lead exposure
17. Immunotoxicity of heavy metals
18. Immune response to Chlamydia pneumoniae in twins in relation to gender and smoking
19. Humoral immune responses to Chlamydia pneumoniae in twin discordant for smoking
20. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers
21. Hepatitis B vaccine responsiveness in Connecticut public safety personel
22. Immune response to vaccine against influenza in smokers, non-smokers, and, in individuals holding respiratory complications
23. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants
24. Influence of season on antibody response to high dose rDNA hepatitis B vaccine: Effects of exposure to solar UVR?
25. The efficacy of DPT and oral poliomyeliotis immunization schedules initiated from birth to 12 weeks of age
26. Immunological Basis for Immunization. 1. General Immunology
27. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age
28. Killed poliovirus antigen titrations in humans
29. Multi-Center Study on the Simultaneous Administration of DPT-IPV and Hib PRP-T Vaccines. Immunogenicity
30. Measles antibody seroprevalence rates among immunized Inuit, Innu, and Caucasian subjects
31. Class II HLA-DR homozygocity is associated with non-response to measles vaccine in U.S children
32. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination
33. The association between HLA class I alleles and measles vaccine-induced antibody response: Evidence of a significant association
34. The influence of the HLA-DRB1*13 allele on measles vaccine response
35. Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus
36. Genetic prediction of nonresponse to hepatitis B vaccine
37. Anti-HBV neonatal immunization with recombinant vaccine. Molecular basis of the impaired alloreactivity
38. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination
39. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen
40. Response to hepatitis B vaccine: Multiple HLA genes are involved
41. The influence of major histocomopatibility complex class II genes and T-cell Vb repertoire on response to immunization with HBsAg
42. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen
43. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells
44. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans
45. Admission criteria for immunogerontological studies in man: The SENIEUR protocol
46. Altered cytokine production in the elderly
47. Characteristics of immunologic test values in the elderly
48. Vaccinating elderly people. Protecting from avoidable disease
49. Prevention and control of influenza A outbreaks in long-term care facilities
50. Immunization of elderly people with high doses of influenza vaccine
51. Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines
52. Failure to respond to influenza vaccine in the aged: Correlation with B-cell number and function
53. Humoral and cellular immune response to influenza virus vaccination in aged humans
54. Failure of influenza vaccination in the aged
55. Antibody induction by influenza vaccines in the elderly: A review of the literature
56. Specific humoral immunity in the elderly: In vivo and in vitro response to vaccination
57. Vaccination against tetanus in the elderly: Do recommended vaccination strategies give sufficient protection
58. Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults
59. Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population
60. Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination
61. Influence of perceived psychological stress and distress on antibody response to low dose rDNA hepatitis B vaccine
62. Modulation of immune response to rDNA hepatitis B vaccination by psychological stress
63. Relationship of stress, distress, and the immunologic response to a recombinant hepatitis B vaccine
64. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine
65. Chronic stress alters the immune response to influenza virus vaccine in older adults
66. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination
67. Effect of stress and other biopsychosocial factors on primary antibody response
68. Effects of malnutrition on smallpox and yellow fever vaccination
69. Protein and calorie malnutrition, cell-mediated immunity, and B.C.G. vaccination in children from rural West Bengal
70. Evaluation of immune response in infants with different nutritional status: Vaccinated against tuberculosis, measles and poliomyelitis
71. Immune responses to measles and smallpox vaccinations in malnourished children
72. Contribution a l'etude de l'efficacite de la vaccination antirougeoleuse chez le jeune enfant Africain malnutri
73. The effect of nutritional status on immune capacity and immune responses in preschool children in a rural community in India
74. Interactions between nutrition and immunity in anorexia nervosa: A 1-y follow-up study
75. Evaluation of nutritional status by immunologic assessment in bulimia nervosa: Influence of body mass index and vomiting episodes
76. An immunological assessment of patients with anorexia nervosa
77. Cell-mediated immunity in anorexia nervosa
78. Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa
79. Protein undernutrition as the major cause of decreased immune function in the elderly: Clinical and functional implications
80. Vitamins and immunocompetence
81. Effects of flavonoids on immune and inflammatory cell functions
82. Antioxidant vitamins and human immune responses
83. Essential nutrients and immunologic functions
84. Synergism of nutrition, infection, and immunity: An overview
85. Immune modulation of blood leukocytes in humans by lactic acid bacteria: Criteria for strain selection
86. Immunosuppressive effects of fish oil in normal human volunteers: Correlation with the in vitro effects of eicosapentanoic acid on human lymphocytes
87. n-3 Polyunsaturated fatty acids and cytokine production in health and disease
88. Nutrition and immunity in the elderly: Modification of immune responses with nutritional treatments
89. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial
90. Is there a relationship between malnutrition, inflammation, and post-vaccinal antibody response to influenza viruses in the elderly?
91. Influence of one virus infection on a second concurrent primary in vivo antiviral cytotoxic T-cell response
92. Microorganisms and their interaction with the immune system
93. Vaccination and systemic diseases. Vaccinations and immunosuppression
94. Hepatitis A vaccine response in HIV-positive persons with haemophilia
95. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: An indicator of poor prognosis
96. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children
97. Factors affecting the immunogenicity and potency of tetanus toxoid: Implications for the elimination of neonatal and non-neonatal tetanus as public health problems
98. Mechanism of suppression of cell-mediated immunity by measles virus
99. Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression
100. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells
101. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
102. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance
103. Immunosuppression induced by attenuated Salmonella: Effect of LPS responsiveness on development of suppression
104. Analysis of the mechanism of immunodepression following heterologous anti-genic stimulation during concurrent infection with Nematospiroides dubius
105. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines
106. Adverse impact of infections on antibody responses to measles vaccination
107. Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines
108. Mild illness at or after measles vaccination does not reduce seroresponse in young children
109. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses
110. Measles vaccination during the respiratory virus season and risk of vaccine failure
111. Measles and rubella antibody response after measles-mumps-rubella vaccination in children with afebrile upper respiratory tract infection
112. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection
113. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children
114. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants
115. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual man
116. Measles revaccination: Persistence and degree of antibody titer by type of immune response